Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
about
The androgen receptor and stem cell pathways in prostate and bladder cancers (review)Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinomaIncidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patientsPathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice.Prognostic value of radical cystoprostatectomy in men with bladder cancer infiltrating prostate versus co-existing prostate cancer: a research study.The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.Novel diagnostic biomarkers for prostate cancer.Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.Prostate cancer trends in Canada: rising incidence or increased detection?Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.The role of prevalence in the diagnosis of prostate cancer.Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.Prostate-sparing cystectomy: has Pandora's box been opened?Prostatic transitional cell carcinoma: pathologic features and clinical management.The pitfalls of lung cancer screening.The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome.Tumor dormancy and the neuroendocrine system: an undisclosed connection?Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study.Synchronous primary malignancies of the male urogenital tract.Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?Usefulness of PSA screening in outpatients with bladder cancer: preliminary results.Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens.Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.Co-existence of mucin-producing urothelial-type adenocarcinoma of the prostate and inverted papilloma of the bladder.The case for prostate capsule-sparing radical cystectomy in selected patients.Should Canadians be offered systematic prostate cancer screening? No.Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.A mathematical model of tumour growth with Beddington-DeAngelis functional response: a case of cancer without disease.Determining transition probabilities from mortality rates and autopsy findings.Prostate cancer screening: promise and peril--a review.Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.Devrait-on offrir aux Canadiens le dépistage systématique du cancer de la prostate?: NON.Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian studyPotentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
P2860
Q26853232-6782343A-EC07-4725-9829-817E89E04FD4Q28139426-F47326EC-C1C2-4DCE-B299-9AC1A47CE283Q28537735-34F82DA9-F3E4-46FA-9559-D9ABEE13AE88Q31133887-F172E713-6BE2-401F-9F33-8789D30EA006Q33699405-270A5AFE-24D1-43EF-ABDE-5780FBB5B8C9Q33958709-9FE4B766-4485-4B0B-9C0D-CA3AECE4B9EBQ33989110-3DF66291-6196-419C-BEE1-DA0E1E719066Q34231678-CC626230-65F1-47D0-ACF0-E2265C6D1483Q34418858-95A899DE-7F92-4469-B20F-DE3ED1E29EECQ34707736-D9E6CAE9-6C94-4321-8611-F338A7365923Q35101958-0BD47721-661F-4B04-8690-27555D07CB8DQ36555644-508AC6F4-4C59-4A15-8EBE-4D5DD4830E81Q36616623-4461D054-31F1-453A-BEB7-24DD5B32A86BQ36879159-8AC2FEA8-5C7B-4AB7-837A-02E8B811A2CCQ37008876-7F16FBC2-EFED-436E-B7E4-BC04026F5FB0Q37077073-8F2C1E3A-148D-45EC-9F5B-835B59AF03A0Q37252255-8E9661AB-2F54-443E-81DF-652003832436Q37905553-FA00910D-9D2B-426E-AD23-DBB7721834D7Q38054489-471F3DB7-2304-43BD-8816-5D1C94B2E9A1Q38211619-55676BFB-F9B4-4C3D-8257-22493AF7C360Q38221133-C0E96BB6-2D8E-40D8-8226-CD2C32D04C2CQ38675168-43CE257B-03AF-477B-89D6-1D35586D7E0DQ39605250-217E9966-B79D-4DE4-B33D-9F342F25391AQ39776834-D1C5D708-B510-46DD-840E-8A1549F8A761Q39781202-48E35EBD-F50D-4B8B-B039-73BB26ED7BCDQ39792361-815D6FCC-96D4-48F1-AE3E-CB31CCE83CEBQ39847388-4AFA49BC-A742-40C3-A550-92BB149AB251Q41691636-DA5F2E4A-A1AD-43BD-AC95-47EFF4A1EB02Q42004216-2D93806D-6BAC-4856-A0B4-332327D91A52Q42414698-8CA5A725-29B1-4E79-AF62-0BC3442D7232Q43914035-35F19823-EE80-4BE6-9EA7-A6499D3F4B45Q45329472-5E97F166-3624-486F-B0E1-985D10EB2278Q47565476-9079940F-0F93-4BD4-8720-6B5B37F60964Q52892128-F1017AA8-5434-4CAF-AE99-D75E26EA4606Q52913704-7493BC5E-2B8B-4881-9CD1-F1BEB53FB2D7Q53324689-11925120-79D4-4957-8C4A-0DBBF98D9062Q55307069-4C9F91D1-89C9-462D-9A06-6B0FA3D99B03Q57642710-0C2BC22A-109A-46D0-9CBD-10D3C2FB6C93Q57643630-694E1059-C1A7-4FDC-9CCD-364B47D7D3A1
P2860
Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@en
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@nl
type
label
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@en
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@nl
prefLabel
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@en
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@nl
P2093
P1433
P1476
Adenocarcinoma of the prostate ...... ns removed for bladder cancer.
@en
P2093
P304
P356
10.1002/1097-0142(19890115)63:2<381::AID-CNCR2820630230>3.0.CO;2-O
P407
P577
1989-01-01T00:00:00Z